EASD 2025: zimislecel infusion advances insulin independence in T1D
At the 2025 European Association for the Study of Diabetes (EASD) meeting in Vienna, investigators reported one-year outcomes from FORWARD,…
All articles by GlobalData Healthcare
GlobalData Healthcare
-
-
Top 20 biopharma market caps fall 5.7% amid industry challenges
The biopharmaceutical industry faces headwinds from the Trump administration’s ongoing tariffs and drug pricing pressures in the US. As a…
-
Cystic fibrosis market forecast to reach $16.0bn by 2034 in the 7MM
The cystic fibrosis (CF) market across the seven major markets (7MM: the US, France, Germany, Italy, Spain, the UK, and…
-
Insmed scores pivotal win in bronchiectasis with FDA approval of Brinsupri
The US Food and Drug Administration (FDA) approval of Insmed’s Brinsupri marks a significant advancement in the treatment landscape of…
-
ESC 2025: Higher leg muscle scores reduce cardiovascular risk independent of BMI
This Monday (1 September) at the European Society of Cardiology (ESC) meeting in Madrid, the link between dietary intake, leg…
-
Four drugs race for first bispecific ADC approval
Bispecific (bs) antibody drug conjugates (ADCs) are an emerging therapeutic approach that present advantages over traditional ADCs. With 84% of…
-
2024 saw growth recovery for almost all top biopharma companies
The biopharmaceutical industry had a positive year in 2024, with obesity drug developers continuing to witness success. 19 of the…
-
AI is improving idiopathic pulmonary fibrosis care
Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease characterised by the accumulation of scar tissue in the lungs, leading…
-
Infectious disease screening during substance use disorder treatment increases detection, prevention, and treatment
According to the US Centers for Disease Control and Prevention, substance use disorder (SUD) affects approximately one in six people…
-
US eosinophilic oesophagitis market to reach $1.19bn by 2030
The eosinophilic oesophagitis (EoE) market in the US is forecast to grow from $202 million in 2020 to $1.19 billion…